Toxoplasma gondii serology in pregnant woman: Characteristics and pitfalls;Sérologie de la toxoplasmose chez la femme enceinte: Caractéristiques et pièges

Annales de Biologie Clinique

Volumn 67, Issue 2, 2009, Pages 125-133

  Flori, P ^a,b   Chene, G ^c   Variet, M N ^c   Tran Manh Sung, R ^a,b  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b UNIVERSITÉ JEAN MONNET   (France)

^c HÔPITAL NORD   (France)

Author keywords

Avaidity; IgG; IgM; Pregnancy; Slogy; Toxoplasmosis

Indexed keywords

TOXOPLASMA GONDII;

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

BLOOD; CONGENITAL TOXOPLASMOSIS; DISEASE TRANSMISSION; FEMALE; HUMAN; IMMUNOLOGY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; REPRODUCIBILITY; REVIEW; SEROLOGY; TOXOPLASMOSIS;

FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; REPRODUCIBILITY OF RESULTS; SEROLOGIC TESTS; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL;

EID: 67549111177     PISSN: 00033898     EISSN: 19506112     Source Type: Journal    
DOI: 10.1684/abc.2009.0308     Document Type: Review

References (33)

1. Duinn D, Wallon M, Peyion F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis : risk estimates tor clinical counselling. Lancet 1999 ; 353 : 1829-1833 (Pubitemid 29251014)
2. Canne B, Tliard-Fleuiy V. La Toxoplasmose chez la femme enceinte en France : séroprévalence, taux de seroconversion et niveau de connaissances des mesures préventives. Tendances 1965-1995. Méd Mal Infect 1996;26:431-436
3. Berger F, Goulet V, Le Strat Y, Desenclos JC. Toxoplasmose chez les femmes enceintes en France : évolution de la séroprévalence et de l'incidence et facteurs associés, 1995-2003. Bull Epidemiol HAd 2008 ; 14: 117-121
4. Villena I. Enjeux et missions du Centre National de Réfé rence de la Toxoplasmose. Spectra Biologie 2008 ; 165 : 17-22.
5. Afssa. Rapport du groupe de travail Toxoplasma gondii. « Toxoplasmose : état des connaissances et évaluation du risque lié à l'alimentation ». Maisons Alfort : Afssa, 2005 : 20.
6. Stray-Pedersen B. Prevention of congenital toxoplasmosis in Norway. Arch Ped 2003 (Suppl. 1) : 23-24
7. Joynson DHM. Congenital toxoplasma infection in the UK. Arch Ped 2003 (SuppL 1) : 27-28
8. AmbroiseThomasP,SchweitzerM,PinonJM,ThiebaugeorgesO.Lapré ventiondelatoxoplasmosecongénitaleenFrance.Evaluationdesrisques. Résultatsetperspectivesdudépistageanté nataletdusuividunouveau-né.BullAcadNatlMed2001;185:665- 688(Pubitemid33632114)
9. PetithoryJC,MilgramM,JanotC,MaisonneuveP,MigueresML,CharrierN,etal.A. Réévaluationde40troussesderéactifspourladé tectiondesanticorpsanti-toxoplasmosedetypeIgG.RevFrLab1998;301:59-64. (Pubitemid128676969)
10. Jenum PA, Stray Pedersen B. Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women. J Clin Microbiol 1998 ; 36 : 2907-2913
11. GoubetS,PellouxH,Fricker-HidalgoH,Gouuier-FleuretA,Ambroise-ThomasP. Sérodiagnosticdelatoxoplasmose:comparaisondelatrousseElisaAxSYM(Abbott) aveclatrousseVidas(bioMérieux),I'immunofluorenceindirecteetl'ISAgA. AnnBiolClin1999;57:481-484(Pubitemid129755215)
12. Petersen E, Borobio MV, Guy E, Liesenfèld O, Meroni V, Naessens A, et al. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-speáñc immunoglobulin G OgG and IgM and the IgG avidity index. J Clin Microbiol 2005 ; 43 : 1570-1574 (Pubitemid 40491190)
13. Chatelain R, Maudry A, Bellete B, Hafid J, Raberin H, Tran Manh Sung R, et al Comparaison de 4 tests automatisés : les tests Toxo IgG I et II Access® (Beckman Coulter), Axsym®(Abbott) et VidaS® (bioMérieux) à partir de 406 sérums tout venant Que dire des seuils proposés. Nice : Congrès SFP et SFMM, 2007.
14. Flori P, Bellete B, Crampe C, Maudry A, Paturai H, Chauleur C, et al. A technique for dating toxoplasmosis in pregnancy and comparison with the Vidas anti-toxoplasma IgG avidity test Clin Microbiol Infect 2008 ; 14: 242-249 (Pubitemid 351201015)
15. Franck J, Garin YJ, Dumon H. LDBio-Toxo II immunoglobulin G western blot confirmatory test for anti-toxoplasma antibody detection. J Clin Microbiol 2008 ; 46 : 2334-2338
16. Foulon W, Villena I, Stray-Pedersen B, et al. Treatment of toxoplasmosis during prenancy - a multicenter study of impact on fetal transmis- sion and children's sequelae at age 1 year. Am J Obstet Gynecol 1999 ; 180:410-415 (Pubitemid 29093877)
17. WilsonM,RemingtonJ,ClavetC,VarneyG,PressC,WareD. EvaluationofsixcommercialkitsfordetectionofhumanimmunoglobulinMantibodies- Toxoplasmagondii.JClinMicrobiol1997;35:3112-3115(Pubitemid27505729)
18. FloriP,HafidJ,RaberinH,PaturalH,VarletMN,TranManhSungR. IntérêtdunouveautestAccess®ToxoIgM(II)dansl'interpré tationsérologiquedelatoxoplasmoseaucoursdelagrossesse.AnnBiolClin2002;60: 65-72.(Pubitemid34136190)
19. Kodym P, Machala L, Rohacova H, Sirocka B, MaIy M. Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis. Clin Microbiol Infect 2007 ; 13 : 40-47 (Pubitemid 44869206)
20. LiesenfeldO,PressC,MontoyaJG,GillR,Isaac-RentonJL,HedmanK,etal. False-positiveresultsinimmunoglobulinM(IgM) Toxoplasmaantibodytestsandimportanceofconfirmatorytesting: theplateliaToxoIgMtestJClinMicrobiol1997;35:174-178(Pubitemid26422649)
21. PellouxH,Fricker-HidalgoH,Goullier-FleuretA,AmbroiseThomasP. Detectionofanti-ToxoplasmaimmunoglobulinMinpregnantwomen.JClinMicrobiol1997;35: 2187.(Pubitemid27318738)
22. Robert-Gangneux F, Kiefier F. Prise en charge diagnostique et thérapeutique de la toxoplasmose congénitale. Lettre Infect 2001 ; 16 : 143-150
23. Pralong F. Toxoplasmose et grossesse : le point sur le suivi sérologique. Gynecol Obstet Fertil 2002 ; 30: 237-243 (Pubitemid 34297528)
24. Sickinger E, Gay-Andrieu F, Jonas G, Schultess J, Stieler M, Smith D, et al. Performance characteristics of the new ARCHITECT Toxo IgG and Toxo IgG Avidity assays. Diagn Microbiol Infect Dis 2008 ; 62 : 235-44.
25. Gras L, Gilbert RE, Wallon M, Peyron F, Cortina-Borja M. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy : implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect 2004 ; 132: 541-548
26. NaotY,RemingtonJS.Anenzyme- linkedimmunosorbentassayfordetectionofIgMantibodies-Toxoplasmagondii: usefordiagnosisofacuteacquiredtoxoplasmosis.JInfectDis1980;142: 757-766(Pubitemid11138431)
27. RobertsA,HedmanK,LuyasuV,etal. MulticenterevaluationofstrategiesforserodiagnosisofprimaryinfectionwithToxoplas magondii.EurJClinMicrobiolInfectDis2001;20:467-474(Pubitemid34212107)
28. Flori P, Tardy L, Patural H, Bellete B, Varlet MN, Hafid J, et al. Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women. Clin Diagn Lab Immunol 2004 ; 11: 669-674 (Pubitemid 38943987)
29. Fricker-Hidalgo H, Saddoux C, Suchel-Jambon AS, Romand S, Foussadier A, Pelloux H, et al New Vidas assay for Toxoplasmaspecific IgG avidity : evaluation on 603 sera. Diagn Microbiol Infect Dis 2006; 56: 167-172 (Pubitemid 44508805)
30. Lefevre-Pettazzoni M, Le Cam S, Wallon M, Peyron F. Delayed maturation of immunoglobulin G avidity : implication for the diagnosis of toxoplasmosis in pregnant women. Eur J Clin Microbiol Infect Dis 2006 ; 25 : 687-693 (Pubitemid 44806776)
31. Remington JS, Thulliez P, Montoya JG. Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol 2004 ; 42: 941-945
32. Whitington PF, Kelly S. Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics 2008 ; 121 : 1615-1621
33. Mundy CA. Intravenous immunoglobulin in the management of hemolytic disease of the newborn. Neonatal Netw 2005 ; 24: 17-24.